Companies / Industrials
XYL
Xylem Inc.
Industrial Machinery & Supplies & Components
Industrial Machinery & Supplies & ComponentsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health67
Growth63
Profitability48
Cash generation59
Balance sheet87
Dilution control76
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)-3.0%Revenue growth (FY)5.5%Revenue CAGR (3y)17.8%Gross margin38.5%Operating margin13.5%Net margin10.6%Free cash flow margin10.1%R&D / revenue2.5%Stock comp / revenue0.6%Net debt / operating cash flow0.81xCurrent ratio1.62Diluted share count change0.2%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $5.2B | $5.5B | $7.4B | $8.6B | $9.0B |
| Gross profit | $2.0B | $2.1B | $2.7B | $3.2B | $3.5B |
| Operating income | $585M | $622M | $652M | $1.0B | $1.2B |
| Net income | $427M | $355M | $609M | $890M | $957M |
| Operating cash flow | $538M | $596M | $837M | $1.3B | $1.2B |
| Capital expenditure | $208M | $208M | $271M | $321M | $331M |
| Free cash flow | $330M | $388M | $566M | $942M | $910M |
| R&D | $204M | $206M | $232M | $230M | $226M |
| Stock-based comp | $33M | $37M | $60M | $56M | $53M |
| Buybacks | $68M | $52M | $25M | $20M | $15M |
| Dividends | $203M | $217M | $299M | $350M | $391M |
| Cash | $1.3B | $944M | $1.0B | $1.1B | $1.5B |
| Total debt | $2.4B | $1.9B | $2.3B | $2.1B | $2.5B |
| Equity | $3.2B | $3.5B | $10.2B | $10.6B | $11.5B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.